In contrast, Donnem et al. demonstrated that an elevated level of mir-126 expression is associated with a shorter survival period in patients with NSCLC and that an elevated level of mir-126 expression was associated with an increase in VEGF-A expression in NSCLC (Donnem et al., 2011). This evidence concerns the gene VEGFA and non-small cell lung carcinoma.